Where this topic shows up
Our markets on respiratory, by category.
- Medical Devices · 3
- OTC & Nutraceuticals · 1
- Pharmaceuticals · 1
Market reports
Worldwide reports first. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Airway Management Devices
Worldwide · 2024–2034
View report Medical DevicesAnesthesia & Respiratory Devices
Worldwide · 2024–2034
View report Medical DevicesAnti-Snoring Devices
Worldwide · 2024–2034
View report PharmaceuticalsAsthma & COPD Drugs
Worldwide · 2024–2034
View report OTC & NutraceuticalsOver The Counter (OTC) Medications for Cough, Cold & Flu Drugs
Worldwide · 2024–2034
View reportFree public health charts
Live data from public sources. The line shows the world (or US) trend.
Deaths from air pollution
2019–2019 · per 100,000 people
Deaths caused by indoor and outdoor air pollution for every 100,000 people (age-standardised).
Compare placesFine dust in the air (PM2.5)
2010–2023 · µg per m³
Average amount of fine particles (PM2.5) in the air people breathe.
Compare placesChronic lung disease (CLRD) death rate
2003–2017 · deaths per 100,000 people (age-adjusted)
Deaths from chronic lung disease (clrd) for every 100,000 people, adjusted so states with older…
Compare placesKey companies
Named as key players in the most of these markets.
AstraZeneca2 markets here
Koninklijke Philips N.V.2 markets here
Medtronic2 markets here
AbbVie Inc.1 market here
Ambu A/S1 market here
Amgen Inc.1 market here
Apnea Sciences1 market here
Bayer AG1 market here
Boehringer Ingelheim GmbH1 market here
Bristol-Myers Squibb Company1 market here
Drägerwerk AG & Co. KGaA1 market here
F. Hoffmann-La Roche Ltd1 market here
All markets on this topic
Each opens the market's statistics page, with every country we cover.
Medical Devices
OTC & Nutraceuticals
Pharmaceuticals
Related topics
Need research on respiratory?
Full reports carry researched sizes, forecasts and company profiles. We also build custom studies.
Acuitas market figures are supplied with each full report. Chart data comes from the public sources named on each chart.